Proprietary imaging technology for evaluating Quality of Slides and FFPE Blocks - % tumor, % necrosis...
Proprietary imaging technology to assess region of interest (ROI) for selection of tumor content for NextGen Sequencing
Where possibilities become realities.
TriMetis Life Sciences is leveraging its experience to change the centuries old methods of manual quality control of biospecimens.
Dedicated to helping you accelerate your tissue-based business through access to quality biospecimens, innovative quality control technology and research expertise.
Viable Tissue Area
Tumor Nuclei count
Optimal Core Identification
Significant Cost savings
Leverage our global access for accurate and timely delivery.
Ai IMAGE Analysis
Use Artificial Intelligence to screen and identify new features in the tissues.
TriMetis is dedicated to the advancement of medical research.
Supporting diagnostic, pharmaceutical, biotech, and academic institutions by increasing productivity through the acquisition of high-quality biospecimens utilizing our proprietary quality control systems.
TriMetis’ team started as researchers (genomics, proteomics, and clinical research) with an vital need for high-quality biospecimens. Decades of experience have led us to invest and develop innovative technologies to proof the quality of biospecimens.
Our Quality Control System provides quantitative and qualitative data on the quality of a biospecimen before it is used.
Ideal for any Formalin-fixed Paraffin Embedded (FFPE) based technology, NextGen (DNA/RNA) Sequencing, Immunohistochemsitry, Ai developers, and biobankers.
Contact us today to learn how we can help you elevate your research!